FDA Approves Rusfertide in Polycythemia Vera
FDA Approves Rusfertide in Polycythemia Vera CancerNetwork
Regulatory Approvals
This Week at FDA: HHS considering new FDA posts, FDA approves slew of firsts, and more
This Week at FDA: HHS considering new FDA posts, FDA approves slew of firsts, and more RAPS
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer Targeted Oncology
FDA Approves Rusfertide for Polycythemia Vera
FDA Approves Rusfertide for Polycythemia Vera OncLive
FDA approves first RAS-targeting drug for pancreatic cancer
FDA approves first RAS-targeting drug for pancreatic cancer Drug Discovery News